These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 30105458)
1. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity. Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458 [TBL] [Abstract][Full Text] [Related]
2. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin. Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329 [TBL] [Abstract][Full Text] [Related]
3. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study. Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of a Undiluted, One-Bag Desensitization Protocol for Chemotherapeutic Agents. Iglesias-Santamaría A; Castellano Copa P Ann Pharmacother; 2023 Jan; 57(1):55-61. PubMed ID: 35570798 [TBL] [Abstract][Full Text] [Related]
5. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions. Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization. Wong JT; Ling M; Patil S; Banerji A; Long A J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767 [TBL] [Abstract][Full Text] [Related]
7. Rechallenges without desensitization following platinum-based chemotherapy reactions. Young FD; Aung S; Tang M; Anstey KM; Lee MC; Alfaro E; Cinar P; Ho H; Otani IM J Oncol Pharm Pract; 2024 Apr; 30(3):572-575. PubMed ID: 38347725 [TBL] [Abstract][Full Text] [Related]
8. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions. Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265 [TBL] [Abstract][Full Text] [Related]
9. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors. Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181 [TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol. Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137 [TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492 [TBL] [Abstract][Full Text] [Related]
12. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions. Markman M; Hsieh F; Zanotti K; Webster K; Peterson G; Kulp B; Spicel A; Belinson J J Cancer Res Clin Oncol; 2004 Jan; 130(1):25-8. PubMed ID: 14564516 [TBL] [Abstract][Full Text] [Related]
13. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study. Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546 [TBL] [Abstract][Full Text] [Related]
14. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. Wang AL; Patil SU; Long AA; Banerji A Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407 [TBL] [Abstract][Full Text] [Related]
16. Platinum Chemotherapy Hypersensitivity: Prevalence and Management. Otani IM; Wong J; Banerji A Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633 [TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Gammon D; Bhargava P; McCormick MJ Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639 [TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment. Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576 [TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272 [TBL] [Abstract][Full Text] [Related]
20. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers. Zwimpfer TA; Scherer K; Schötzau A; Heinzelmann-Schwarz V; Hartmann K; Vetter M; Montavon C Cancer Med; 2024 Jan; 13(1):e6840. PubMed ID: 38140783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]